Unstable angina:refractory: thoracic epidural anaesthesia reduced episodes of angina and ischaemia.
|
|
|
Clinical bottom line (level 1b)
-
Patients with severe refractory unstable angina who had thoracic epidural anaesthesia had fewer episodes of ischaemia
(NNT =
3
at 48
hours)
and angina
(NNT =
1
at 48
hours)
.
-
Ischaemic attacks were shorter (by a mean 16 minutes).
-
Side effects were common (urinary retention and Horner's syndrome)
(NNH =
2
at 48
hours)
, but are reversible.
|
|
Olausson et al:
Circulation
1997;
96 (7):
2178-2182
|
Expires
June 2003
|
The study
Unblinded concealed randomised
trial
without
intention-to-treat
Setting: coronary care unit, university hospital, Sweden
40 patients
(aged
mean 65 years,
81%
male)
severe refractory unstable angina
- typical chest pain occurring at rest associated with reversible ST-segment depression 0.1 mV or more, 60 msecs after the J-point, no development of new Q waves and maximal rise of CK-MB less than twice the upper normal limit
- treatment with aspirin and/or heparin infusion
- treatment with beta-blockers
- treatment with nitroglycerin iv for more than 24 hours at an optimal infusion rate according to ischaemic symptoms and side effects
- recurrence of chest pain or more severe chest pain during at least one attempt to discontinue the nitroglycerin infusion
Control Group: (n = 20, 18 analysed):
continued maximal medical therapy
Experimental Group: (n = 20, 18 analysed):
thoracic epidural anaesthesia (at one of T2 to T5 intercostal spaces)- bolus of 20-30 mg of
bupivicaine
(5mg/ml) followed by a continuous infusion for 48 hours (7.5-16 mg/hour) to maintain loss of temperature sensation to T1-T5. Heparin was discontinued 5 hours before the procedure, and nitroglycerin within 5 hours of anaesthesia working. All other medication was continued.
90% followed for
48
hours
Outcome notes:
-
ischaemic episode
: on 24 hour ambulatory monitoring (reversible ST-segment changes lasting one minute, with a shift of =0.1 mV, 60 ms after the J-point)
-
side effects
: urinary retention, Horner's syndrome
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| ischaemic episode
|
48
hours |
11 (61.1%) |
4 (22.2%) |
64% (7% to
86%) |
38.9% (9.29% to
68.5%) |
3
(1 to
11)
|
| anginal attack
|
48
hours |
15 (83.3%) |
1 (5.56%) |
93% (55% to
99%) |
77.8% (57.6% to
98.0%) |
1
(1 to
2)
|
| side effects
|
48
hours |
0 (0.00%) |
10 (55.6%) |
inf% (% to
%) |
-55.6% (-78.5% to
-32.6%) |
-2
(-3 to
-1)
|
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| length of ischaemic attack (min)
|
19.7
(6.20)
|
4.10
(2.50)
|
15.6
(12.4 to 18.8)
|
- All side effects of thoracic anaesthesia were reversible on decreasing the dose of bupivicaine.
Comments
- Small study - potentially serious side effects may be missed.
- Short length of follow-up- what is the effect on overall mortality and infarctions?
Citation
-
Olausson
K,
Magnusdottir
H,
Lurje
L, et al:
Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris.
Circulation
1997;
96 (7):
2178-2182
Search Terms:
unstable angin* in Cochrane
Contributor: Chris Ball and Clare Wotton,
June 2000
Reviewer: Kenneth Ballew
Clinical Question.
| Patient |
severe unstable angina |
| Intervention or Exposure |
thoracic epidural anaesthesia |
| Comparison |
continued maximal medical therapy |
| Outcome |
ischaemic episode, anginal attack, side effects |
|
|